Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.

Identifieur interne : 002889 ( PubMed/Corpus ); précédent : 002888; suivant : 002890

Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.

Auteurs : Brian T. Helfand ; Norm D. Smith ; James M. Kozlowski ; Mark K. Eskandari

Source :

RBID : pubmed:20889305

English descriptors

Abstract

Inferior vena cava (IVC) reconstruction for locally advanced renal cell carcinoma (RCC) includes resection with and without interposition grafting, patch graft, or primary repair. The proposed benefits of lateral venorrhaphy and primary repair are avoidance of foreign material, a more expeditious repair, and preservation of lower extremity venous outflow.

DOI: 10.1016/j.avsg.2010.05.020
PubMed: 20889305

Links to Exploration step

pubmed:20889305

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.</title>
<author>
<name sortKey="Helfand, Brian T" sort="Helfand, Brian T" uniqKey="Helfand B" first="Brian T" last="Helfand">Brian T. Helfand</name>
<affiliation>
<nlm:affiliation>Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Smith, Norm D" sort="Smith, Norm D" uniqKey="Smith N" first="Norm D" last="Smith">Norm D. Smith</name>
</author>
<author>
<name sortKey="Kozlowski, James M" sort="Kozlowski, James M" uniqKey="Kozlowski J" first="James M" last="Kozlowski">James M. Kozlowski</name>
</author>
<author>
<name sortKey="Eskandari, Mark K" sort="Eskandari, Mark K" uniqKey="Eskandari M" first="Mark K" last="Eskandari">Mark K. Eskandari</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20889305</idno>
<idno type="pmid">20889305</idno>
<idno type="doi">10.1016/j.avsg.2010.05.020</idno>
<idno type="wicri:Area/PubMed/Corpus">002889</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002889</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.</title>
<author>
<name sortKey="Helfand, Brian T" sort="Helfand, Brian T" uniqKey="Helfand B" first="Brian T" last="Helfand">Brian T. Helfand</name>
<affiliation>
<nlm:affiliation>Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Smith, Norm D" sort="Smith, Norm D" uniqKey="Smith N" first="Norm D" last="Smith">Norm D. Smith</name>
</author>
<author>
<name sortKey="Kozlowski, James M" sort="Kozlowski, James M" uniqKey="Kozlowski J" first="James M" last="Kozlowski">James M. Kozlowski</name>
</author>
<author>
<name sortKey="Eskandari, Mark K" sort="Eskandari, Mark K" uniqKey="Eskandari M" first="Mark K" last="Eskandari">Mark K. Eskandari</name>
</author>
</analytic>
<series>
<title level="j">Annals of vascular surgery</title>
<idno type="eISSN">1615-5947</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Carcinoma, Renal Cell (mortality)</term>
<term>Carcinoma, Renal Cell (pathology)</term>
<term>Carcinoma, Renal Cell (surgery)</term>
<term>Chicago</term>
<term>Female</term>
<term>Humans</term>
<term>Kidney Neoplasms (mortality)</term>
<term>Kidney Neoplasms (pathology)</term>
<term>Kidney Neoplasms (surgery)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasm Recurrence, Local</term>
<term>Nephrectomy (adverse effects)</term>
<term>Retrospective Studies</term>
<term>Thrombectomy (adverse effects)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Vascular Patency</term>
<term>Vena Cava, Inferior (pathology)</term>
<term>Vena Cava, Inferior (physiopathology)</term>
<term>Vena Cava, Inferior (surgery)</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Chicago</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Nephrectomy</term>
<term>Thrombectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Carcinoma, Renal Cell</term>
<term>Kidney Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Carcinoma, Renal Cell</term>
<term>Kidney Neoplasms</term>
<term>Vena Cava, Inferior</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Vena Cava, Inferior</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Carcinoma, Renal Cell</term>
<term>Kidney Neoplasms</term>
<term>Vena Cava, Inferior</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasm Recurrence, Local</term>
<term>Retrospective Studies</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Vascular Patency</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Inferior vena cava (IVC) reconstruction for locally advanced renal cell carcinoma (RCC) includes resection with and without interposition grafting, patch graft, or primary repair. The proposed benefits of lateral venorrhaphy and primary repair are avoidance of foreign material, a more expeditious repair, and preservation of lower extremity venous outflow.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20889305</PMID>
<DateCreated>
<Year>2010</Year>
<Month>12</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>04</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2010</Year>
<Month>12</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1615-5947</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>25</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2011</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Annals of vascular surgery</Title>
<ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.</ArticleTitle>
<Pagination>
<MedlinePgn>39-43</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2010.05.020</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Inferior vena cava (IVC) reconstruction for locally advanced renal cell carcinoma (RCC) includes resection with and without interposition grafting, patch graft, or primary repair. The proposed benefits of lateral venorrhaphy and primary repair are avoidance of foreign material, a more expeditious repair, and preservation of lower extremity venous outflow.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A single-center retrospective review of 22 patients with RCC and IVC tumor thrombus treated with radical nephrectomy, lateral venorrhaphy, thrombectomy, and primary vena cava repair between July 2002 and June 2009 was carried out. Demographic data, diagnostic information, radiographic cross-sectional imaging, and procedural outcomes were examined.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 13 men and nine women, the mean age was 62.1 years (42-83); mean tumor size was 9.8 cm (3-17 cm), and 90% (n = 18) of the cases with RCC were identified pathologically as clear cell adenocarcinoma; on the basis of the classification system adopted by Neves, level I was for 50% (n = 11), level II for 32% (n = 7), level III for 9% (n = 2), and level IV for 9% (n = 2) of the patients. All patients underwent en bloc radical nephrectomy with tumor thrombus removal and primary IVC repair. Mean total operative time was 547.9 ± 138.5 minutes, whereas mean IVC cross-clamp time was 10.8 minutes (6-29 minutes). There were no intraoperative deaths or pulmonary embolism and all IVC margins were found to be pathologically negative. Postoperative complications included one pulmonary embolism, one exacerbation of chronic lymphedema, and two cases of new onset erectile dysfunction. Mean follow-up was 36.4 ± 23.2 months (6-92 months). There were no radiographic or clinically significant changes in mean IVC diameter during follow-up. Five late deaths (23%) occurred as a result of metastatic RCC over a mean period of 24 months (range, 12-48), but without any local recurrences.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">For advanced RCC with tumor thrombus extension into the IVC, lateral venorrhaphy and primary IVC repair avoids complicated caval reconstructions and results in high patency rates with a low local tumor recurrence rate.</AbstractText>
<CopyrightInformation>Copyright © 2011 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Helfand</LastName>
<ForeName>Brian T</ForeName>
<Initials>BT</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Norm D</ForeName>
<Initials>ND</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kozlowski</LastName>
<ForeName>James M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Eskandari</LastName>
<ForeName>Mark K</ForeName>
<Initials>MK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Ann Vasc Surg</MedlineTA>
<NlmUniqueID>8703941</NlmUniqueID>
<ISSNLinking>0890-5096</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002292" MajorTopicYN="N">Carcinoma, Renal Cell</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002641" MajorTopicYN="N" Type="Geographic">Chicago</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009392" MajorTopicYN="Y">Nephrectomy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017131" MajorTopicYN="Y">Thrombectomy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014654" MajorTopicYN="N">Vascular Patency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014682" MajorTopicYN="N">Vena Cava, Inferior</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>02</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2010</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2010</Year>
<Month>05</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20889305</ArticleId>
<ArticleId IdType="pii">S0890-5096(10)00299-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.avsg.2010.05.020</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002889 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002889 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:20889305
   |texte=   Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:20889305" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024